Screening for Gestational Diabetes by Measuring Fasting Plasma Glucose Levels

Objectives: (a) To test the sensitivity and specificity of measuring fasting plasma glucose levels (FPG) as a screening test for gestational diabetes mellitus (GDM). (b) To compare predicting levels of FPG levels with the one-hour, oral 50g non-fasting glucose challenge test (GCT) for predicting GDM...

Full description

Bibliographic Details
Main Authors: Khalil E. Rajab, Jonathan H. Skerman, Abdulla A. Issa
Format: Article
Language:English
Published: Sultan Qaboos University 2003-04-01
Series:Sultan Qaboos University Medical Journal
Subjects:
Online Access:https://journals.squ.edu.om/index.php/squmj/article/view/1238
id doaj-dfe7ae0567b8429da8ac01ad310ab5f1
record_format Article
spelling doaj-dfe7ae0567b8429da8ac01ad310ab5f12020-11-25T03:33:06ZengSultan Qaboos UniversitySultan Qaboos University Medical Journal 2075-051X2075-05282003-04-0151581167Screening for Gestational Diabetes by Measuring Fasting Plasma Glucose LevelsKhalil E. Rajab0Jonathan H. Skerman1Abdulla A. Issa2Department of Obstetrics and Gynaecology, , Arabian Gulf University, College of Medicine and Medical Sciences, Salmaniya Medical Complex, P.O.Box 26752, Manama, Kingdom of Bahrain.Department of Anaesthesia and Intensive Care, Arabian Gulf University, College of Medicine and Medical Sciences, Salmaniya Medical Complex, P.O.Box 26752, Manama, Kingdom of Bahrain.Department of Obstetrics and Gynaecology, , Arabian Gulf University, College of Medicine and Medical Sciences, Salmaniya Medical Complex, P.O.Box 26752, Manama, Kingdom of Bahrain.Objectives: (a) To test the sensitivity and specificity of measuring fasting plasma glucose levels (FPG) as a screening test for gestational diabetes mellitus (GDM). (b) To compare predicting levels of FPG levels with the one-hour, oral 50g non-fasting glucose challenge test (GCT) for predicting GDM. Methods: One thousand and six hundred pregnant women from the Health Centres, antenatal clinics and Salmaniya Medical Complex were screened by the GCT after 50g of oral glucose during 26–32 weeks gestation, giving a 13.5% incidence of GDM (using the Third International Workshop cutoff values of 7.8 mmol /l). All patients also had an FPG estimation followed by the three-hour oral glucose tolerance test (oGTT). Seventy eight percent of the patients were Bahraini, 19% Asian and 3% other nationalities. Their mean age was 27.2+0.2 years. Receiver-operating curves (ROC) were used to test the ability of the FPG and the oGTT to differentiate patients with GDM and identify the cut off values for predicting a diagnosis of GDM. Results: FPG levels of 5.6 mmol /l and 5.4 mmol /l yielded sensitivities and specificities of 94% and 93% respectively. Measuring FPG as a screening test required a diagnostic oGTT in 32% compared with 13% when the GCT was used. Conclusion: Using FPG levels at a cutoff value of ≥ 5.5 mmol /l is an easier, more acceptable test for patients compared to the GCT. Using the FPG levels is also more cost effective and allows nearly 70% of women to avoid the oGTT.https://journals.squ.edu.om/index.php/squmj/article/view/1238gestational diabetes, pregnancy, screening, fasting plasma glucose levels.
collection DOAJ
language English
format Article
sources DOAJ
author Khalil E. Rajab
Jonathan H. Skerman
Abdulla A. Issa
spellingShingle Khalil E. Rajab
Jonathan H. Skerman
Abdulla A. Issa
Screening for Gestational Diabetes by Measuring Fasting Plasma Glucose Levels
Sultan Qaboos University Medical Journal
gestational diabetes, pregnancy, screening, fasting plasma glucose levels.
author_facet Khalil E. Rajab
Jonathan H. Skerman
Abdulla A. Issa
author_sort Khalil E. Rajab
title Screening for Gestational Diabetes by Measuring Fasting Plasma Glucose Levels
title_short Screening for Gestational Diabetes by Measuring Fasting Plasma Glucose Levels
title_full Screening for Gestational Diabetes by Measuring Fasting Plasma Glucose Levels
title_fullStr Screening for Gestational Diabetes by Measuring Fasting Plasma Glucose Levels
title_full_unstemmed Screening for Gestational Diabetes by Measuring Fasting Plasma Glucose Levels
title_sort screening for gestational diabetes by measuring fasting plasma glucose levels
publisher Sultan Qaboos University
series Sultan Qaboos University Medical Journal
issn 2075-051X
2075-0528
publishDate 2003-04-01
description Objectives: (a) To test the sensitivity and specificity of measuring fasting plasma glucose levels (FPG) as a screening test for gestational diabetes mellitus (GDM). (b) To compare predicting levels of FPG levels with the one-hour, oral 50g non-fasting glucose challenge test (GCT) for predicting GDM. Methods: One thousand and six hundred pregnant women from the Health Centres, antenatal clinics and Salmaniya Medical Complex were screened by the GCT after 50g of oral glucose during 26–32 weeks gestation, giving a 13.5% incidence of GDM (using the Third International Workshop cutoff values of 7.8 mmol /l). All patients also had an FPG estimation followed by the three-hour oral glucose tolerance test (oGTT). Seventy eight percent of the patients were Bahraini, 19% Asian and 3% other nationalities. Their mean age was 27.2+0.2 years. Receiver-operating curves (ROC) were used to test the ability of the FPG and the oGTT to differentiate patients with GDM and identify the cut off values for predicting a diagnosis of GDM. Results: FPG levels of 5.6 mmol /l and 5.4 mmol /l yielded sensitivities and specificities of 94% and 93% respectively. Measuring FPG as a screening test required a diagnostic oGTT in 32% compared with 13% when the GCT was used. Conclusion: Using FPG levels at a cutoff value of ≥ 5.5 mmol /l is an easier, more acceptable test for patients compared to the GCT. Using the FPG levels is also more cost effective and allows nearly 70% of women to avoid the oGTT.
topic gestational diabetes, pregnancy, screening, fasting plasma glucose levels.
url https://journals.squ.edu.om/index.php/squmj/article/view/1238
work_keys_str_mv AT khalilerajab screeningforgestationaldiabetesbymeasuringfastingplasmaglucoselevels
AT jonathanhskerman screeningforgestationaldiabetesbymeasuringfastingplasmaglucoselevels
AT abdullaaissa screeningforgestationaldiabetesbymeasuringfastingplasmaglucoselevels
_version_ 1724564690207506432